| Target Price | $13.77 |
| Price | $1.36 |
| Potential |
912.50%
register free of charge
|
| Number of Estimates | 4 |
|
4 Analysts have issued a price target Virios Therapeutics Inc 2027 .
The average Virios Therapeutics Inc target price is $13.77.
This is
912.50%
register free of charge
$15.75
1,058.09%
register free of charge
$12.12
791.18%
register free of charge
|
|
| A rating was issued by 8 analysts: 7 Analysts recommend Virios Therapeutics Inc to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Virios Therapeutics Inc stock has an average upside potential 2027 of
912.50%
register free of charge
|
| Analyst | Rating | Action | Date |
|---|---|---|---|
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | May 19 2026 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Apr 27 2026 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Feb 20 2026 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Jan 30 2026 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Sep 30 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Apr 23 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Oct 09 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
May 19 2026 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Apr 27 2026 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Feb 20 2026 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Jan 30 2026 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Sep 30 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Apr 23 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Oct 09 2024 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


